SYNTAX Study: SYNergy Between PCI With TAXUS and Cardiac Surgery.

Trial Profile

SYNTAX Study: SYNergy Between PCI With TAXUS and Cardiac Surgery.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Aug 2017

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms SYNTAX; SYNTAX-LE-MANS
  • Sponsors Boston Scientific Corporation
  • Most Recent Events

    • 30 Aug 2017 Results describing lesion characteristics and stenting techniques as predictors of long-term outcomes after PCI of bifurcation lesions in the SYNTAX trial, presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology.
    • 20 Sep 2016 Pooled analysis (n=1166) of individual patient-level data of the SYNTAX and BEST trials published in the Heart.
    • 06 Sep 2016 Results (n=1305) of a pooled analysis of individual patient-level data from SYNTAX and PRECOMBAT trials, published in the Journal of the American College of Cardiology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top